Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026838 (
spasticity
)
6,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study examined the feasibility of an adapted 2-week mindfulness meditation protocol for chronic stroke survivors. In addition, preliminary effects of this adapted intervention on
spasticity
and quality of life in individuals after stroke were explored. Ten chronic stroke survivors with
spasticity
listened to 2 weeks of short mindfulness meditation recordings, adapted from
Jon
Kabat-Zinn's Mindfulness-Based Stress Reduction course, in a pre/post repeated measures design. Measures of
spasticity
, quality of life, mindfulness, and anxiety, along with qualitative data from participants' daily journals, were assessed. On average, participants reported meditating 12.5 days of the full 15 days (mean 12.5 days, SD 0.94, range 8-15 days). Seven of the 10 participants wrote comments in their journals. In addition, there were no adverse effects due to the intervention. Exploratory preliminary analyses also showed statistically significant improvements in
spasticity
in both the elbow (
P
= .032) and wrist (
P
= .023) after 2 weeks of meditation, along with improvements in quality of life measures for Energy (
P
= .013), Personality (
P
= .026), and Work/Productivity (
P
= .032). This feasibility study suggests that individuals with
spasticity
following stroke are able to adhere to a 2-week home-based mindfulness meditation program. In addition, preliminary results also suggest that this adapted, short mindfulness meditation program might be a promising approach for individuals with
spasticity
following stroke. Future research should expand on these preliminary findings with a larger sample size and control group.
...
PMID:Mindfulness Meditation Effects on Poststroke Spasticity: A Feasibility Study. 3121 34